Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Activated factor VIIa use in acute intracerebral hemorrhage with coagulopathy has low symptomatic thromboembolic complication rates

Activated factor VIIa use in acute intracerebral hemorrhage with coagulopathy has low symptomatic thromboembolic complication rates. Critical Care Medicine. 2009; 37(12):A422.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.